Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
140,800
Employees140,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
140,800
Employees140,800

JNJ Key Statistics

Market cap
567.65B
Market cap567.65B
Price-Earnings ratio
27.85
Price-Earnings ratio27.85
Dividend yield
2.18%
Dividend yield2.18%
Average volume
7.37M
Average volume7.37M
High today
$240.00
High today$240.00
Low today
$233.58
Low today$233.58
Open price
$239.01
Open price$239.01
Volume
6.98M
Volume6.98M
52 Week high
$251.71
52 Week high$251.71
52 Week low
$149.04
52 Week low$149.04

Stock Snapshot

As of today, Johnson & Johnson(JNJ) shares are valued at $235.66. The company's market cap stands at 567.65B, with a P/E ratio of 27.85 and a dividend yield of 2.2%.

On 2026-06-15, Johnson & Johnson(JNJ) stock traded between a low of $233.58 and a high of $240.00. Shares are currently priced at $235.66, which is +0.9% above the low and -1.8% below the high.

Johnson & Johnson(JNJ) shares are trading with a volume of 6.98M, against a daily average of 7.37M.

During the past year, Johnson & Johnson(JNJ) stock moved between $149.04 at its lowest and $251.71 at its peak.

During the past year, Johnson & Johnson(JNJ) stock moved between $149.04 at its lowest and $251.71 at its peak.

JNJ News

TipRanks 4h
J&J, Bristol-Myers face negotiation risk under new CMS rule, says RBC Capital

RBC Capital analyst Trung Huynh tells investors in a research note that CMS on Friday proposed making the Medicare Drug Price Negotiation Program permanent begi...

Simply Wall St 6h
How Investors Are Reacting To Johnson & Johnson Multiple Myeloma Trial Data For TALVEY Combinations

Earlier this month, Johnson & Johnson reported late-stage trial results showing its bispecific antibody TALVEY, combined with DARZALEX FASPRO with or without po...

How Investors Are Reacting To Johnson & Johnson Multiple Myeloma Trial Data For TALVEY Combinations
TipRanks 9h
Johnson & Johnson Boosts Vision Operations in $55B U.S. Manufacturing Push

Pharma giant Johnson & Johnson (JNJ) has found a new target for its four-year $55 billion U.S. manufacturing expansion plan launched in March 2025. The company...

Analyst ratings

68%

of 25 ratings
Buy
68%
Hold
28%
Sell
4%

More JNJ News

TipRanks 10h
Johnson & Johnson invests more than $1B in Jacksonville, Florida

Johnson & Johnson announced an investment of more than $1B in Jacksonville, Florida to strengthen its Vision operations by scaling U.S.-based manufacturing, pac...

24/7 Wall St. 1d
A $750,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

A $750,000 Portfolio That Quietly Pays You More Than the Average Social Security Check By Drew Wood Published Jun 14, 6:29AM EDT Quick Read A $750,000 income...

A $750,000 Portfolio That Quietly Pays You More Than the Average Social Security Check
24/7 Wall St. 2d
Why a Dividend Portfolio That Pays Your Rent May Beat Homeownership by $500,000 Over 20 Years

Why a Dividend Portfolio That Pays Your Rent May Beat Homeownership by $500,000 Over 20 Years By Drew Wood Published Jun 13, 8:02AM EDT Quick Read A $686,000...

Why a Dividend Portfolio That Pays Your Rent May Beat Homeownership by $500,000 Over 20 Years
NPR 2d
Eric Johnson of the band Fruit Bats discusses their album, 'The Landfill' - NPR

...

Eric Johnson of the band Fruit Bats discusses their album, 'The Landfill' - NPR
TipRanks 3d
Top Johnson & Johnson Executive Makes a Major Insider Cash Move

New insider activity at Johnson & Johnson ( (JNJ) ) has taken place on June 12, 2026. Kathryn E. Wengel, Executive Vice President, Chief TO and Risk Officer at...

Nasdaq 3d
Johnson & Johnson Just Paid $1 Billion for a Technology That Could Crack One of Cancer's Most "Undruggable" Targets. Why That's Very Good News for Investors.

Key Points Cancer remains the pharmaceutical industry's biggest business, as well as one of its fastest-growing. Some technological leaps complement existing...

Johnson & Johnson Just Paid $1 Billion for a Technology That Could Crack One of Cancer's Most "Undruggable" Targets. Why That's Very Good News for Investors.
Simply Wall St 3d
Johnson & Johnson’s TECNIS PureSee Rollout And What It Means For JNJ Stock

Johnson & Johnson (NYSE:JNJ) has expanded U.S. availability of its TECNIS PureSee intraocular lens, described as the first FDA approved extended depth of focus...

Johnson & Johnson’s TECNIS PureSee Rollout And What It Means For JNJ Stock

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.